Bronstein, Gewirtz & Grossman, LLC Launches Investigation: A Closer Look at the Company’s Business and Professional Services Announcement

marketinsider05 mins

Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims Against Customers Bancorp, Inc. On March 16, 2025, Bronstein, Gewirtz & Grossman, LLC, a leading national securities fraud law firm, announced that it is investigating potential claims on behalf of purchasers of Customers Bancorp, Inc. (CUBI) securities. The investigation focuses on allegations of securities fraud and other…

Read More

Arizona Sonoran Unveils Promising Pre-Feasibility Study for Cactus Mine Project: $509M Post-Tax NPV and 55 KSTPA Copper Cathode Production Over 21 Years

newscaster04 mins

Arizona Sonoran Announces Positive Pre-Feasibility Study for Cactus Mine Project CASA GRANDE, Ariz. & TORONTO–(BUSINESS WIRE)–$ASCU #Arizona Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (“ASCU” or the “Company”) today announced it has completed its NI 43-101 Prefeasibility Study (“PFS”) for its Cactus Project in Arizona, USA. The Standalone PFS outlines a lower risk, top…

Read More

Innovative, Articulate, and Easy to Follow: Ethereum Foundation Sees New 100 ETH Sell-Off as Price Falls

financenews02 mins

The Ethereum Foundation’s Latest ETH Sell-Off Overview The Ethereum Foundation has recently conducted its third ETH sell-off of the year. According to data from Onchain Lens, the organization sold 100 ETH for 307,893 DAI at an average price of $3,078.93. Analysis This move by the Ethereum Foundation is a strategic decision to manage its funds…

Read More

Facebook Financial Corporation: Unpacking the Secrets to Their Continuous Success and Growth

ilikefinance04 mins

FB Financial Corporation: A Strong Performance with Improved Efficiency and Solid Liquidity FB Financial Corporation (FBK), the banking subsidiary of FirstBank, recently reported impressive financial results for the latest quarter. The company’s earnings growth was marked by a 13% increase in Earnings Per Share (EPS) and a 20% rise in adjusted pre-tax revenue. Improved Operational…

Read More

D-Boral Capital Plays Matchmaker: Exclusively Connecting Plus Therapeutics with Investors

ilikefinance04 mins

Plus Therapeutics Announces $15.0 Million Private Placement for CNS Cancer Research On March 4, 2025, Plus Therapeutics, Inc. (Nasdaq: PSTV), a pioneering clinical-stage pharmaceutical company specializing in the development of targeted radiotherapeutics and advanced platform technologies for central nervous system (CNS) cancers, announced the pricing of a private placement. This financing round is expected to…

Read More